ES2108014T3 - Composicion antiviral de 3'-azido-2',3'-dideoxi-5-metilcitidina. - Google Patents

Composicion antiviral de 3'-azido-2',3'-dideoxi-5-metilcitidina.

Info

Publication number
ES2108014T3
ES2108014T3 ES90911253T ES90911253T ES2108014T3 ES 2108014 T3 ES2108014 T3 ES 2108014T3 ES 90911253 T ES90911253 T ES 90911253T ES 90911253 T ES90911253 T ES 90911253T ES 2108014 T3 ES2108014 T3 ES 2108014T3
Authority
ES
Spain
Prior art keywords
dideoxi
methylcitidine
azido
antiviral composition
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90911253T
Other languages
English (en)
Inventor
Chung K Chu
Raymond F Schinazy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
University of Georgia Research Foundation Inc
Original Assignee
Emory University
University of Georgia Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University, University of Georgia Research Foundation Inc filed Critical Emory University
Application granted granted Critical
Publication of ES2108014T3 publication Critical patent/ES2108014T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

UNA COMPOSICION QUE ACARREA UNA CANTIDAD INHIBIDORA DE HIV DE UN COMPUESTO ACTIVO DE FORMULA GENERAL (I), DONDE R ES OH, MONOFOSFATO, DIFOSFATO O TRIFOSFATO O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LO ANTERIOR, Y DONDE ACTUA COMO UN PORTADOR FARMACEUTICAMENTE ACEPTABLE. EN OTRA DISPOSICION DE ESTA INVENCION, UNA DOSIS DE 3''-AZIDO-2'',3''-DIDEOXI 5-METILCITIDINA, O SUS DERIVADOS ES ADMINISTRADA EN UN PORTADOR FARMACEUTICAMENTE ACEPTABLE A UN PACIENTE PARA EL TRATAMIENTO DEL SIDA.
ES90911253T 1989-06-07 1990-06-06 Composicion antiviral de 3'-azido-2',3'-dideoxi-5-metilcitidina. Expired - Lifetime ES2108014T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/362,756 US5084445A (en) 1986-05-01 1989-06-07 3'-azido-2',3'-dideoxy-5-methylcytidine

Publications (1)

Publication Number Publication Date
ES2108014T3 true ES2108014T3 (es) 1997-12-16

Family

ID=23427415

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90911253T Expired - Lifetime ES2108014T3 (es) 1989-06-07 1990-06-06 Composicion antiviral de 3'-azido-2',3'-dideoxi-5-metilcitidina.

Country Status (8)

Country Link
US (1) US5084445A (es)
EP (1) EP0476066B1 (es)
JP (1) JP2941942B2 (es)
AT (1) ATE157252T1 (es)
DE (1) DE69031340T2 (es)
DK (1) DK0476066T3 (es)
ES (1) ES2108014T3 (es)
WO (1) WO1990014831A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911470B1 (en) 1988-09-22 2005-06-28 Raymond F. Schinazi Polyoxometalate compounds as antiviral agents
US5506349A (en) * 1992-05-13 1996-04-09 Ribozyme Pharmaceuticals, Inc. Chemical synthesis of 2', 3'-dideoxycytidine
JPH07508022A (ja) * 1992-05-13 1995-09-07 リボザイム・ファーマシューティカルズ・インコーポレイテッド ヌクレオチドモノマー類の合成
US5407927A (en) * 1993-04-16 1995-04-18 The Regents Of The University Of California Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
US6432924B1 (en) 1993-12-26 2002-08-13 East Carolina University Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
US5824706A (en) * 1994-09-26 1998-10-20 Schinazi; Raymond F. Method, compositions, and apparatus for treating and preventing respiratory viral infections
KR19990076695A (ko) * 1995-12-22 1999-10-15 리차드 알. 이킨 시티딘 데아미나제 혹은 데옥시시티딘 데아미나제의 과발현과연관된 질병들을 치료하기 위한 활성제_및 방법
PE20000066A1 (es) * 1997-12-22 2000-02-09 Schering Corp Formas de dosificacion solida de ribavirina administrables oralmente y proceso de fabricacion
CA2335617C (en) * 1998-06-24 2009-12-15 Novirio Pharmaceuticals Limited Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
US6407077B1 (en) 1998-11-05 2002-06-18 Emory University β-L nucleosides for the treatment of HIV infection
WO2000026225A2 (en) 1998-11-05 2000-05-11 Centre National De La Recherche Scientifique Nucleosides with anti-hepatitis b virus activity
US20030083304A1 (en) * 2001-10-09 2003-05-01 Smart Robert C. CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment
CN102014919B (zh) 2008-03-03 2015-02-25 托斯克公司 减少毒性的甲氨蝶呤佐剂及其使用方法
GB201001088D0 (en) 2010-01-23 2010-03-10 Trillion Genomics Ltd Detection
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions
CN114276359B (zh) * 2022-01-05 2023-05-05 浙江大学 一种1,2,3,4-四氢苯并[4,5]呋喃[2,3-c]吡啶衍生物的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282921A (en) * 1964-06-04 1966-11-01 Syntex Corp Halo-deoxynucleosides and processes for the preparation thereof
US3755295A (en) * 1969-10-24 1973-08-28 Syntex Corp 1-(2-amino-2-deoxy-{62 -d-ribofuranosyl) pyrimidines and derivatives thereof
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
US3687931A (en) * 1970-03-19 1972-08-29 Syntex Corp Halogenated purine and pyrimidine nucleosides and process therefor
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
DE2627076A1 (de) * 1976-06-16 1977-12-29 Max Planck Gesellschaft Mittel zur inhibierung des zellwachstums
US4071680A (en) * 1976-12-20 1978-01-31 Hoffmann-La Roche Inc. 5'-Deoxy-5-fluoropyrimidine nucleosides
US4093715A (en) * 1977-04-28 1978-06-06 Research Corporation 5-Iodo-5'-amino-2',5'-dideoxycytidine and the pharmaceutically acceptable salts thereof
US4093716A (en) * 1977-04-28 1978-06-06 Research Corporation Compositions containing 5-amino-5-deoxythymidine and pharmaceutically acceptable salts thereof
US4128639A (en) * 1977-12-14 1978-12-05 Research Corporation Nitrosourea analogs of thymidine
US4210638A (en) * 1978-03-17 1980-07-01 Pcr, Inc. Antiviral composition and method of treating virus diseases
US4230689A (en) * 1979-05-01 1980-10-28 Sue Choy Hair grooming composition of matter
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4604382A (en) * 1983-01-17 1986-08-05 Research Corporation 3'-amino-2',3'-dideoxycytidine and the pharmacologically acceptable salts thereof
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
DD224490A1 (de) * 1984-04-30 1985-07-10 Adw Ddr Verfahren zur herstellung eines virostatischen mittels
ATE113603T1 (de) * 1985-03-16 1994-11-15 Wellcome Found Antivirale nukleoside.
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
DE3650741T2 (de) * 1985-09-17 2000-10-12 The Wellcome Foundation Ltd., Greenford Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
US4710492A (en) * 1986-06-23 1987-12-01 Yale University 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
EP0286825A3 (en) * 1987-03-18 1989-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of 3'-fluro-3' deoxythymidine for the manufacture of a medicament for the treatment of virus infections
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus

Also Published As

Publication number Publication date
US5084445A (en) 1992-01-28
HK1014660A1 (en) 1999-09-30
DE69031340D1 (de) 1997-10-02
DE69031340T2 (de) 1998-01-15
EP0476066B1 (en) 1997-08-27
WO1990014831A3 (en) 1991-01-24
JP2941942B2 (ja) 1999-08-30
EP0476066A1 (en) 1992-03-25
JPH05504940A (ja) 1993-07-29
DK0476066T3 (da) 1997-09-22
ATE157252T1 (de) 1997-09-15
WO1990014831A2 (en) 1990-12-13

Similar Documents

Publication Publication Date Title
ES2108014T3 (es) Composicion antiviral de 3'-azido-2',3'-dideoxi-5-metilcitidina.
US4861759A (en) Antiviral compositions and methods
ES2157929T3 (es) Beta-d-dioxolano-nucleosidos enantiomeramente puros.
US4963533A (en) Therapeutic application of dideoxycytidinene
ES2106794T3 (es) Utilizacion del inositol-trifosfato para el tratamiento de inflamaciones.
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
RU95110698A (ru) Способ лечения инфекций, вызываемых вирусом гепатита в
BR0312286A (pt) pró-medicamentos de 2' e 3' - nucleosìdeo modificado para tratamento de infecções por flaviviridae
JPS6425A (en) Medicinal composition for treating hiv infection containing dsrna and reverse transcriptase inhibitor
PT99300A (pt) Processo para a preparacao de composicoes farmaceuticas para a terapia de afeccoes neurologicas em doentes com sida que contem, como ingrediente activo, pelo menos um composto escolhido do grupo que consiste em sais de s-adenosilmetionina, acido 5-metiltetra-hidrofolico e acido 5-formiltetra-hidrofolico e os seus sais
DE68921760D1 (de) Behandlung von beschädigtem knochenmark und dosierungseinheiten dafür.
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
JPS63107936A (ja) 後天性免疫不全症ａｉｄｓに対する医薬
BR0316397A (pt) Tiouréias aril substituìdas e compostos relacionados como inibidores de replicação viral
ES2129485T3 (es) Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
SE8406538D0 (sv) Novel derivatives of purine
ATE173627T1 (de) Medizinische zusammensetzung
TNSN89039A1 (fr) Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales
KR900002786A (ko) 비루스 치료방법
US5254539A (en) Method of treating HIV with 2',3'-dideoxyinosine
CO4520283A1 (es) Agentes antivirales
AR013994A1 (es) Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes.
JPH0215524B2 (es)
ES2148234T3 (es) Composicion farmaceutica a base de flavopereirina y su utilizacion en el tratamiento del virus vih.
MX9301922A (es) Composiciones para el tratamiento de infeccion y enfermedad ocasionadas por el virus de hepatitis b (hbv).

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 476066

Country of ref document: ES